Results 11 to 20 of about 401,073 (266)
Current Status of the Diagnosis and Management of Osteoporosis
International Journal of Molecular Sciences, 2022 Osteoporosis has been defined as the silent disease of the 21st century, becoming a public health risk due to its severity, chronicity and progression and affecting mainly postmenopausal women and older adults.
A. Aibar-Almazán +5 more
semanticscholar +1 more source
Osteoporosis in Europe: a compendium of country-specific reports
Archives of Osteoporosis, 2022 Summary This report describes epidemiology, burden, and treatment of osteoporosis in each of the 27 countries of the European Union plus Switzerland and the UK (EU 27+2).
C. Willers +8 more
semanticscholar +1 more source
Best Practice & Research Clinical Rheumatology, 1995 Two complementary notions need to be considered in the definition of osteoporosis: a reduction in bone mineral density and the occurrence of fracture. Bone mineral density is an established determinant of the risk of future fracture, but current interventions are most usefully targeted before bone density has fallen to the levels at which fractures ...
C, Cooper, A, Aihie
openaire +4 more sources
Evolution, Medicine, and Public Health, 2015 Version of ...
Wallace, Ian J. +2 more
openaire +3 more sources
BMC Musculoskeletal Disorders, 2021 Background Recent research has suggested that cardiotrophin-like cytokine factor 1 (CLCF1) may be an important regulator of bone homeostasis. Furthermore, a whole gene chip analysis suggested that the expression levels of CLCF1 in the peripheral blood ...
Xuan Chen +8 more
doaj +1 more source
Simulating pharmaceutical treatment effects on osteoporosis via a bone remodeling algorithm targeting hypermineralized sites [PDF]
Medical Engineering and Physics, Elsevier, 2020, 76, pp.56 - 68, 2021 Pharmaceutical treatments can slow bone degradation, thus reducing the fracture risk inherent in osteoporosis. Antiresorptive treatments block the over-activation of osteoclasts vs osteoblasts, but the resulting decrease in bone remodeling frequency may weaken bone structure over time, with no gain in bone volume.
arxiv +1 more source
Pharmacogenetics of osteoporosis [PDF]
Best Practice & Research Clinical Endocrinology & Metabolism, 2010 Osteoporosis is a complex bone disorder with a strong genetic basis. The genetics of osteoporosis encompasses two main areas: genetics of disease susceptibility and pharmacogenetics of drug response. The former has been widely studied in the past few decades, while the latter is still largely untouched.
MARINI, FRANCESCA, BRANDI, MARIA LUISA
openaire +10 more sources
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Osteoporosis International, 2014 The Clinician’s Guide to Prevention and Treatment of Osteoporosis was developed by an expert committee of the National Osteoporosis Foundation (NOF) in collaboration with a multispecialty council of medical experts in the field of bone health convened by
F. Cosman +6 more
semanticscholar +1 more source
New England Journal of Medicine, 2001 BACKGROUND Once-daily injections of parathyroid hormone or its amino-terminal fragments increase bone formation and bone mass without causing hypercalcemia, but their effects on fractures are unknown.
R. Neer +11 more
semanticscholar +1 more source